SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jun 17, 2026

ARQT

Arcutis Biotherapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed5mo ago
Insider cluster: 2 insiders, $221K total
Actionable Insight • Neutral

The cluster is too small to convey a bearish signal. Monitor for larger insider moves or C-suite participation before drawing conclusions. The company's strong analyst consensus (86% bullish) and recent institutional accumulation suggest no near-term concern.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$26.21
T+0 close · Jun 17, 2026 · via day close
Latest settled
−7.40%
T+60 · $24.27
Vs SPY
−9.30%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 18 $26.21entry
  2. T+1 · 5mo ago +1.72%α +2.03% · $26.66
  3. T+5 · 5mo ago +1.83%α +3.50% · $26.69
  4. T+20 · 4mo ago +5.84%α +5.30% · $27.74
  5. T+60 · 2mo ago −7.40%α −9.30% · $24.27
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two directors at Arcutis Biotherapeutics sold a combined $221K in open-market transactions over a 7-day window. The total value represents approximately 0.007% of the company's $3.2B market cap, making this a trivial cluster with no material signal for traders.

Key Financial Metrics

Direction
selling
Total Value
$221.0K
Insiders
2

Key Facts

  • Two directors (Welgus Howard G. and LIN SUE-JEAN) sold shares totaling $221K
  • Total sales represent ~0.007% of ARQT's $3.2B market cap
  • Welgus also exercised non-cash derivative transactions (822 shares at $0 and 822 shares at $6.52) alongside the sales
  • No C-suite executives participated in the cluster

Financial Impact

Insider sales of $221K, negligible relative to $3.2B market cap

insider ownership

Risk Factors

  • Insider selling could accelerate if stock price continues to rise, but current levels are routine

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ARQT-1781743656282

Track record

34 reports on ARQT

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +21.34% at T+60 after the Aug 5, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 13, 20263d ago Press Release Neutral 4/10 Entry $28.26 Now $27.15 −3.93% settles Feb 11
  2. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $27.39 Now $27.15 −0.86% settles Feb 8
  3. Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $25.55 Now $27.15 +6.26% settles Feb 4
  4. Nov 4, 202612d ago 3/A / CLUSTER / 3 Neutral 2/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
  5. Nov 4, 202612d ago 144 Neutral 3/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
  6. Nov 4, 202612d ago 424B5 Bearish 4/10 Entry $27.00 Now $27.15 −0.56% settles Feb 3
  7. Nov 4, 202612d ago 8-K Neutral 5/10 No price data
  8. Nov 4, 202612d ago Press Release Mixed 6/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
  9. Nov 2, 202614d ago 144 Neutral 2/10 Entry $32.00 Now $27.15 −15.16% settles Feb 1
  10. Nov 2, 202614d ago 144 Neutral 2/10 Entry $32.00 Now $27.15 −15.16% settles Feb 1
Showing 10 of 34

US Market Status

Market Closed · Opens Wed (10h 5m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 17, 2026